Skip to main content
Figure 1 | BMC Musculoskeletal Disorders

Figure 1

From: The potential role of advanced glycation end products (AGEs) and soluble receptors for AGEs (sRAGE) in the pathogenesis of adult-onset still’s disease

Figure 1

Comparison of plasma levels of (A) AGEs and (B) soluble RAGE (sRAGE) among 30 patients with active adult-onset Still’s disease (AOSD), 22 patients with inactive AOSD, 25 patients with active systemic lupus erythematosus (SLE), 11 patients with inactive SLE, and 16 healthy subjects (HC). The horizontal line indicates median value for each group. *p < 0.05, **p < 0.005, ***p < 0.001, was determined by Mann–Whitney U test.

Back to article page